Recruiting Xeroderma Pigmentosum Studies in New York
About Xeroderma Pigmentosum Clinical Trials in New York
Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.
There are currently 6 xeroderma pigmentosum clinical trials recruiting participants in New York, NY. These studies are seeking a combined 42,427 participants. Research is being sponsored by NYU Langone Health, Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Xeroderma Pigmentosum Clinical Trials in New York — FAQ
Are there xeroderma pigmentosum clinical trials in New York?
Yes, there are 6 xeroderma pigmentosum clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What xeroderma pigmentosum treatments are being tested?
The 6 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for xeroderma pigmentosum.
Data updated July 19, 2026 from ClinicalTrials.gov